---
figid: PMC7312468__ijms-21-04055-g001
figtitle: The MNK1/2-eIF4E axis
organisms:
- Mus musculus
- Rattus norvegicus
- Cricetulus griseus
- Homo sapiens
- Coronaviridae
pmcid: PMC7312468
filename: ijms-21-04055-g001.jpg
figlink: pmc/articles/PMC7312468/figure/ijms-21-04055-f001/
number: F1
caption: Schematic of the MNK1/2-eIF4E axis. The red stars on the NRAS, RAF, and NF1
  indicate the three common subtypes of cutaneous melanoma. Mutations in BRAF result
  in the hyperactivation of the mitogen-activated protein kinase (MAPK) pathway while
  mutations in NRAS or NF1 result in the hyperactivation of both MAPK and phosphoinositide
  3-kinase (PI3K) pathways. Activating mutations in c-KIT results in hyperactivation
  of Ras and downstream effector pathways. Signaling down the MAPK pathway results
  in the activation of MNK1/2 and signaling down the PI3K/Akt pathway results in the
  hyperphosphorylation of 4E-BP and the resultant release of eIF4E to associate with
  eIF4G. MNK1/2 bind to eIF4G and phosphorylate eIF4E at Ser209. This results in enhanced
  translation of certain mRNAs. MNK1 and MNK2 may also be phosphorylated by p38 through
  stress-mediated signals.
papertitle: The MNK1/2-eIF4E Axis as a Potential Therapeutic Target in Melanoma.
reftext: Sathyen A. Prabhu, et al. Int J Mol Sci. 2020 Jun;21(11):4055.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9582863
figid_alias: PMC7312468__F1
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Cricetulus griseus
redirect_from: /figures/PMC7312468__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7312468__ijms-21-04055-g001.html
  '@type': Dataset
  description: Schematic of the MNK1/2-eIF4E axis. The red stars on the NRAS, RAF,
    and NF1 indicate the three common subtypes of cutaneous melanoma. Mutations in
    BRAF result in the hyperactivation of the mitogen-activated protein kinase (MAPK)
    pathway while mutations in NRAS or NF1 result in the hyperactivation of both MAPK
    and phosphoinositide 3-kinase (PI3K) pathways. Activating mutations in c-KIT results
    in hyperactivation of Ras and downstream effector pathways. Signaling down the
    MAPK pathway results in the activation of MNK1/2 and signaling down the PI3K/Akt
    pathway results in the hyperphosphorylation of 4E-BP and the resultant release
    of eIF4E to associate with eIF4G. MNK1/2 bind to eIF4G and phosphorylate eIF4E
    at Ser209. This results in enhanced translation of certain mRNAs. MNK1 and MNK2
    may also be phosphorylated by p38 through stress-mediated signals.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Kit
  - Nras
  - Nf1
  - Pten
  - Pik3r1
  - Braf
  - Braf-rs1
  - Mdk
  - Map2k1
  - Map2k2
  - Map2k3
  - Map2k6
  - Mtor
  - Mapk3
  - Mapk1
  - Mapk14
  - Mapk11
  - Mknk2
  - Mknk1
  - Eif4e
  - Ng
  - Ebp
  - Pabpc1
  - Pabpc2
  - H2-Aa
  - KIT
  - NRAS
  - NF1
  - MTG1
  - PTEN
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - BRAF
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - MAP2K3
  - MAP2K6
  - MTOR
  - MAPK3
  - MAPK1
  - MAPK14
  - MAPK11
  - MKNK2
  - MKNK1
  - EIF4E
  - EIF4E2
  - EIF4E3
  - EIF4A1
  - EIF4A2
  - EIF4A3
  - EIF4G1
  - EIF4G2
  - EIF4G3
  - PABPC1
  - Pck1
  - Pik3cg
  - imatinib
  - nilotinib
  - dasatinib
  - vemurafenib
  - dabrafenib
  - encorafenib
  - cobimetinib
  - trametinib
  - binimetinib
  - LY2275796
  - cercosporamide
  - CGP57380
  - Silvestrol
  - Pateamine A
  - Hippuristanol
---
